Piedmont Newton Hospital | |
5126 Hospital Drive Ne, Covington, Georgia 30014 | |
(770) 786-7053 | |
Name | Piedmont Newton Hospital |
---|---|
Type | Acute Care Hospital |
Location | 5126 Hospital Drive Ne, Covington, Georgia |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 110018 |
NPI Number | 1255891958 |
Organization Name | PIEDMONT NEWTON EKG BILLING LLC |
Address | 5126 Hospital Dr Ne, Covington, GA 30014 |
Hospital Type | General Acute Care Hospital |
Phone Number | 770-786-7053 |
News Archive
Fullerenes have attracted considerable attention in different fields of science since their discovery in 1985. Investigations of physical, chemical and biological properties of fullerenes have yielded promising information. It is inferred that size, hydrophobicity, three-dimensionality and electronic configurations make them an appealing subject in medicinal chemistry. Their unique carbon cage structure coupled with immense scope for derivatization make them a potential therapeutic agent.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
› Verified 3 days ago
NPI Number | 1699930586 |
Organization Name | NEWTON MEDICAL CENTER |
Address | 5126 Hospital Dr Ne, Covington, GA 30014 |
Hospital Type | General Acute Care Hospital |
Phone Number | 770-385-7053 |
News Archive
Fullerenes have attracted considerable attention in different fields of science since their discovery in 1985. Investigations of physical, chemical and biological properties of fullerenes have yielded promising information. It is inferred that size, hydrophobicity, three-dimensionality and electronic configurations make them an appealing subject in medicinal chemistry. Their unique carbon cage structure coupled with immense scope for derivatization make them a potential therapeutic agent.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
› Verified 3 days ago
NPI Number | 1760498588 |
Organization Name | PIEDMONT NEWTON HOSPITAL, INC. |
Doing Business As | NEWTON MEDICAL CENTER |
Address | 5126 Hospital Dr Ne, Covington, GA 30014 |
Hospital Type | General Acute Care Hospital |
Phone Number | 770-385-4426 |
News Archive
Fullerenes have attracted considerable attention in different fields of science since their discovery in 1985. Investigations of physical, chemical and biological properties of fullerenes have yielded promising information. It is inferred that size, hydrophobicity, three-dimensionality and electronic configurations make them an appealing subject in medicinal chemistry. Their unique carbon cage structure coupled with immense scope for derivatization make them a potential therapeutic agent.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
› Verified 3 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Fullerenes have attracted considerable attention in different fields of science since their discovery in 1985. Investigations of physical, chemical and biological properties of fullerenes have yielded promising information. It is inferred that size, hydrophobicity, three-dimensionality and electronic configurations make them an appealing subject in medicinal chemistry. Their unique carbon cage structure coupled with immense scope for derivatization make them a potential therapeutic agent.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
› Verified 3 days ago
Piedmont Newton Hospital Acute Care Hospital Location: 5126 Hospital Drive Ne, Covington, Georgia 30014 Phone: (770) 786-7053 |